News about Global Pharma

Novartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System

Novartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System

The acquisition provides Novartis with full rights to IFM Due's portfolio of STING antagonists, which have the potential to treat an array of serious inflammation-driven diseases characterized by excessive interferon and other pro-inflammatory cytokine signaling.

Global Pharma | 13/03/2024 | By Manvi 462

Casio Introduces DZ-C100 COLPOCAMERA and CST-100M Camera Stand to US, Australia and New Zealand

Casio Introduces DZ-C100 COLPOCAMERA and CST-100M Camera Stand to US, Australia and New Zealand

Alongside the devices, the image management software D'z IMAGE Viewer C is also available in these regions, marking a significant expansion of Casio's medical device offerings.

Global Pharma | 13/03/2024 | By Abha 581

AstraZeneca India and Mankind Pharma Collaborate to Expand Access to Asthma Treatment Across India

AstraZeneca India and Mankind Pharma Collaborate to Expand Access to Asthma Treatment Across India

India currently accounts for 13 percent of the global asthma burden and a staggering 43 percent of asthma-related deaths worldwide.

Global Pharma | 13/03/2024 | By Abha 733

ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins to Improve Cancer Detection

ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins to Improve Cancer Detection

The Johns Hopkins Kimmel Cancer Center was one of the first to be recognized by the National Cancer Institute as a 'Center of Excellence.'

Global Pharma | 12/03/2024 | By Manvi 501

Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals

Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals

The collaboration aims to significantly accelerate the development and commercialization of Ratio's pipeline of next-generation radiotherapies, representing a critical component in advancing Ratio's fibroblast activation protein-alpha (FAP)-targeted radiotherapeutic candidate.

Global Pharma | 12/03/2024 | By Manvi 810

Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers

Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers

Christian Dallner, SBM's product manager, highlights the standardized basis of the SBM Essential Line, which promises shorter delivery times and competitive prices for pharmaceutical manufacturers.

Global Pharma | 12/03/2024 | By Abha 1038

Gennova BioPharma Announces the Launch of HAMSYL Junior

Gennova BioPharma Announces the Launch of HAMSYL Junior

Gennova Biopharmaceuticals Ltd., announces the launch of the India’s first paediatric pack size of pegaspargase – HAMSYL – Junior, which will now be available in a 1500 IU pack size.

Global Pharma | 11/03/2024 | By Manvi 1212

NRx Pharmaceuticals Completes MoU and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

NRx Pharmaceuticals Completes MoU and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

These are important steps to providing a full suite of ketamine options for customers across the country, and preparation for potential approval of HTX-100 by regulatory authorities worldwide.

Global Pharma | 11/03/2024 | By Manvi 365

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity

Obesity and overweight afflict approximately 70 percent of American adults, posing grave health hazards that elevate the likelihood of premature mortality and a spectrum of health ailments, including heart attack and stroke.

Global Pharma | 11/03/2024 | By Abha 1168

PulseCath Achieves MDR CE Certification for iVAC 2L System

PulseCath Achieves MDR CE Certification for iVAC 2L System

This certification signifies PulseCath's unwavering dedication to upholding the highest standards of quality and safety in medical device technology.

Global Pharma | 11/03/2024 | By Abha 438

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members